Lenvatinib Mesylate and Nuwiq recombinant
Determining the interaction of Lenvatinib Mesylate and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-NuZole
- Lenvatinib Mesylate-Nuzyra
- Lenvatinib Mesylate-Nuzyra (Omadacycline Injection)
- Lenvatinib Mesylate-Nuzyra (Omadacycline Tablets)
- Lenvatinib Mesylate-Nuzyra Intravenous
- Lenvatinib Mesylate-Nuzyra oral/injection
- Nuwiq recombinant-Lenvima
- Nuwiq recombinant-Lenvima (14 MG Daily Dose)
- Nuwiq recombinant-Lenvima (18 MG Daily Dose)
- Nuwiq recombinant-Lenvima (20 MG Daily Dose)
- Nuwiq recombinant-Lenvima (24 MG Daily Dose)
- Nuwiq recombinant-Lenvima (8 MG Daily Dose)